Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA:688506)

SHA:688506 Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	3,708	-780.5	-282.38	-99.99
Depreciation & Amortization	79.46	64.72	62.94	53.14
Other Amortization	3.46	2.31	1.79	1.08
Loss (Gain) From Sale of Assets	0	-0.15	0.02	-0.01
Asset Writedown & Restructuring Costs	0.22	0.29	0.46	6.13
Loss (Gain) From Sale of Investments	-30.68	-0	-	-3.14
Provision & Write-off of Bad Debts	0.58	-6.65	7.58	-3
Other Operating Activities	73.65	40.74	27.79	9.45
Change in Accounts Receivable	275.68	73.6	-142.62	62.89
Change in Inventory	-42.14	-52.56	-23.96	-22.22
Change in Accounts Payable	70.92	35.92	107.12	-121.61
Change in Other Net Operating Assets	21.07	-0.04	0.03	-0.06
Operating Cash Flow	4,059	-615.35	-258.65	-135.03
Capital Expenditures	-83.86	-81.94	-34.56	-44.6
Sale of Property, Plant & Equipment	0.1	0.06	0.01	0.07
Investment in Securities	-2,512	-	-	197.2
Other Investing Activities	30.68	0	-	3.48
Investing Cash Flow	-2,565	-81.88	-34.55	156.15
Long-Term Debt Issued	1,904	447.7	467.54	302
Long-Term Debt Repaid	-572.18	-312.94	-220.82	-184.21
Net Debt Issued (Repaid)	1,332	134.76	246.72	117.79
Issuance of Common Stock	-	-	907.47	-
Common Dividends Paid	-38.36	-18.77	-12.59	-26.97
Other Financing Activities	-19.5	-25.14	-2.19	-2.16
Financing Cash Flow	1,274	90.84	1,139	88.66
Foreign Exchange Rate Adjustments	49.19	-2.62	0.26	-0.76
Net Cash Flow	2,816	-609	846.47	109.01
Free Cash Flow	3,975	-697.29	-293.21	-179.63
Free Cash Flow Margin	68.26%	-124.10%	-41.69%	-22.55%
Free Cash Flow Per Share	9.92	-1.74	-0.81	-0.50
Cash Income Tax Paid	428.2	48.98	36.6	101.05
Levered Free Cash Flow	2,692	-396	-145.1	-135.4
Unlevered Free Cash Flow	2,719	-380.58	-131.05	-129.97
Change in Working Capital	224.46	63.88	-76.86	-98.68

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.